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Prediction of the effect of formulation on the 
toxicity of chemicals 
Pritesh Mistry a, Daniel Neagu a, Antonio Sanchez-Ruiz b, Paul R Trundle a, 
Jonathan D. Vessey b, John Paul Gosling c 
Two approaches for the prediction of which of two vehicles will result in lower toxicity for 
anticancer agents are presented.  Machine-learning models are developed using decision tree, 
random forest and partial least squares methodologies and statistical evidence is presented to 
demonstrate that they represent valid models.  Separately, a clustering method is presented that 
allows the ordering of vehicles by the toxicity they show for chemically-related compounds. 
 
Introduction 
When considering the formulation of a drug compound, many 
factors must be taken into account: maintaining the efficacy is 
one of the most important, but for some classes of drug 
compounds formulation to reduce toxicity becomes important 
too.  This is particularly true for cytotoxic compounds where 
several formulation strategies to reduce toxicity have been 
used.1–6 
Perhaps the simplest change in formulation is to change the 
dosing vehicle.  Investigations into the effect of vehicle on 
toxicity have been done in the past.  For example, differences in 
halocarbon toxicity using corn oil or an aqueous Emulphor 
vehicle have been investigated by several groups 7–11 with 
differences in toxicity due to the vehicle also being dependent 
on the type of toxicity – developmental, hepatotoxic and renal – 
as well as the dose. Similarly, aliphatic nitrile compounds have 
been investigated: Farooqui et al.12 showed that the toxicity of 
unsaturated aliphatic nitriles in Sprague-Dawley rats was 
reduced by using corn oil, safflower oil, mineral oil, olive oil or 
Tween-20 rather than saline.  In contrast, Ghanayem et al.13 
found that administration of methacrylonitrile in safflower oil 
was more toxic than in water.   
The prediction of the toxicity of chemicals using machine-
learning methods has been underway for many years14–17 and is 
sufficiently mature to support both freely available18–21 and 
commercial22–25 in silico models. Models are based on 
mechanistic rationale (expert systems) or statistical 
correlations, and both approaches have gained regulatory 
acceptance for prediction of mutagenicity of genotoxic 
impurities.26 
In an earlier paper27, we described the prediction of the effect of 
the dosing vehicle on toxicity; repurposed data from the United 
States National Institute of Health (NIH)28 was used to generate 
dose-survival curves for drugs administered using either saline 
or carboxymethylcellulose (CMC), and it was found that 
machine-learning (ML) methods could correctly classify 
compounds as having lower toxicity when administered with 
one of the two vehicles. 
In this paper, we consider how to demonstrate that the 
relationships that we found previously can be considered to be 
statistically significant and use the same approach to establish 
models for other pairs of vehicles. 
As data for even a single compound tested using two different 
vehicles, with other factors being kept the same, are rare, we 
have also investigated how clusters of compounds containing 
similar chemical groups show a difference in toxicity for 
vehicle pairs, allowing the building of sets of vehicles ordered 
by their relative toxicity when used as vehicles for compounds 
in the cluster. 
Background 
The dataset 
The dataset that was used is described in detail in our previous 
publication27.  The data have been collated over many years 
between the 1950’s and 1980’s by the National Cancer 
Institute’s Developmental Therapeutics program (DTP).28  The 
dataset was created to record the effect of drug compounds on 
animals that had been inoculated with a cancer cell line.  
Experiments were done using sets of, typically, 6 – 10 animals 
with variations in the dosing regime.  Toxicity was measured 
by considering the survival rate of the animals in the test on a 
particular day.  It is assumed that the death of the animals is due 
to the administered compound rather than the cancer cell line 
due to the short time span of the experiments, typically a few 
days. 
The dataset consists of >2M dose-toxicity data points; these are 
generated from >220k different compounds tested in ~50 
different vehicles.  There are experiments on ~40 different 
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species represented in the dataset with the drug compound 
administered by ten different routes. 
The dataset is free to download with explanatory instructions.28 
The approach to measuring differences in toxicity 
It was hoped that the dataset would contain records where the 
only difference between two experiments was the vehicle with 
which the compound was administered and that it would be 
possible to measure a difference in toxicity where this was the 
case.  The toxicity was measured by the number of surviving 
animals on a specified day.  The difficulty in measuring the 
difference in toxicity due to the vehicle was that relatively few 
experiments were conducted with all other factors being the 
same.  In order to make a comparison between experiments, 
therefore, a judgement was made about which factors must be 
the same and which might be allowed to vary; the following 
factors had to be the same for experiments to be considered 
comparable: administered compound, route of administration, 
host species, number of injections, injection interval, first 
injection day, the number of repetitions, the day on which the 
toxicity was assessed and any restart days.  Where these factors 
were the same, and the vehicle was also the same, the 
experiments could be combined into an aggregate for these 
conditions.  In most cases (18992 out of 26424 for compounds 
tested in either saline or CMC), there was only one set of dose-
survival experiments done in a compound-vehicle combination; 
in other cases, however, there were more.  This means that – for 
these aggregated data – there was both inter- and intra-lab 
variability, both of which are difficult to quantify. 
 
Figure 1: Dose-survival plot of six experiments involving single dose 
intraperitoneal injections of 4-di(2-chloroethyl)aminophenylalanine 
hydrochloride into B2D6F1 (BDF1) mice in CMC by the same screener. 
5-flurouracil is an anti-cancer agent which was tested many 
times in the dataset, usually administered in saline and at doses 
where a typical death rate was zero; this allows some measure 
of both intra- and inter-lab variability. In 1985 different sets of 
experimental conditions where more than one experiment was 
performed by the same screener, 1687 (85%) showed a median 
survival rate of 100%.  Aggregating these to eliminate 
differences from the screener gave 1576 different sets of 
experiments where more than one experiment was performed of 
which 1325 (84%) showed a median survival rate of 100%.  
This suggested that both the intra- and inter-lab variability rates 
were low and were quite similar.  Nevertheless, some 
variability was observed:  Intra-lab variability is demonstrated 
in Figure 1 where six experiments involving the nitrogen 
mustard para-di-(2-chlorethyl)-aminophenylalanine 
hydrochloride in CMC being administered by a single 
intraperitoneal injection by the same screener are shown.  Each 
experiment is compared to its own control; experiments each 
lasted a single day.  The dose range in Figure 1 is plotted 
logarithmically for purposes of illustration.  Two of the six 
experiments, numbers 5 and 6, show exactly the same results.  
Three of the six experiments demonstrate high toxicity in doses 
over ca. 2500 mg/kg/injection.  In the analysis in this paper, the 
mean value of survival at each dose would be included in the 
training data for the model. 
Inter-lab variability is illustrated in Figure 2 which shows the 
results from six experiments where mercaptopurine was 
administered to B2D6F1 (BDF1) mice, intraperitoneal, with a 
single daily injection repeated over nine days with the drug 
administered using saline as the vehicle; the dose range for each 
experiment varies.  For these experiments there is very little 
variation in survival shown over the dose range, all studies 
showing a survival of between 83 and 100%. 
 
Figure 2: Dose-survival plot of six experiments by different screeners where 
mercaptopurine was administered to B2D6F1 (BDF1) mice, intraperitoneal, with a 
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single daily injection repeated over nine days with the drug administered using 
saline as the vehicle. 
Figure 3 shows the studies from Figure 2 in the context of three 
additional studies of the same regime but using CMC as the 
vehicle.  For these experiments, administering the drug in saline 
generally results in a higher survival rate than administering the 
drug in CMC. 
Although generally there is a decrease in survival with 
increasing dose, Figure 1 and Figure 2 show that, not 
infrequently, a set of experiments shows a higher survival (i.e. 
less toxicity) at a higher dose than at a lower dose: this is 
shown, for instance in the experiments in Figure 1 for 
Experiment 1 and Experiment 2 and also in Figure 2 for 
Screener 2.  Such variations are commonly due to the death of a 
single animal from a study.  In this work, such variation is 
considered as ‘noise’. 
 
Figure 3: Variations in survival with dose for several experiments with 
mercaptopurine.  Each line represents an experiment carried out by different 
screeners.  Lines in shades of blue or grey represent six experiments where the 
mercaptopurine was administered in saline and lines in shades of red and orange 
represent three experiments where the mercaptopurine was administered in 
CMC. 
Where the toxicity of a compound has been tested by 
administering it using different vehicles and these other factors 
were equal, the toxicity profiles of the two experiments were 
compared using the area under the dose-survival curve. Where 
a difference in the areas under the dose-survival curve was 
found, the compound is considered to be less toxic when 
administered in one vehicle rather than the other.  
As described previously27, the difference in the area under the 
dose-survival curve (AUC) could be calculated in different 
ways to maximise the areas compared: the three ways 
considered were interpolation only; interpolation with 
extrapolation at the high dose end where possible and 
interpolation with extrapolation at both ends of the dose range 
where possible. 
 
 
 
Figure 4: The dose-survival curves for anthracene dicarbamimidothioate (ATPU) 
hydrochloride administered in saline and CMC.  The area under the saline curve 
is shaded in red and under the CMC curve in green.  For the model building, the 
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areas under the curve to be compared are shown by the blue vertical lines which 
change depending on whether the curves are interpolated only (top), 
extrapolated at high dose (middle) or extrapolated at both high and low dose 
(bottom). 
Interpolation is used where the lowest or highest doses used in 
two experiments differ; a point is added to the larger dose range 
to estimate the survival at the ‘missing’ dose thus defining a 
boundary for the calculation of the areas under the dose-
survival curves.  Extrapolation at high dose is possible where 
the survival has already fallen to zero and at low dose where 
survival at the lowest recorded dose is 100%. 
In Figure 4, the differences in how the area under the dose 
survival curve is illustrated for anthracene 
dicarbamimidothioate (ATPU) hydrochloride administered to 
B2D6F1 (BDF1) mice, intraperitoneal, with a single injection in 
either saline or CMC.  The area under the dose-survival curve 
for the drug administered in saline is shown in pale red, while 
that for the drug administered in CMC is shown in green; the 
limits of the area under the curve are shown as blue vertical 
lines.  In the top diagram, it can be seen that at the highest 
common dose, the survival rate in saline is 0% and so it is 
reasonable to extrapolate this survival rate to higher doses, up 
to Log (Dose /mg/kg/injection) of 4.8; this is shown in the 
second diagram.  Additionally, as the survival rate in saline at 
the lowest common dose is 100% it is reasonable to extrapolate 
to low dose and assume the survival rate will remain the same; 
this is shown in the third diagram.  (Note that in Figure 4, the 
dose axis is shown as Log (Dose/mg/kg/injection).  This is 
purely for purposes of the diagram.) 
Across all the drug-vehicle combinations, it was found that 
there was little difference in the number of compounds that 
showed a difference depending on the method of measuring the 
AUC, although when only using interpolation the median was 
smallest; this is shown in Figure 5.  
 
Figure 5: Boxplot of the variation in the number of compounds across all vehicle 
pairs considered to show a significant difference in the area under the dose-
survival curve with the interpolation or extrapolation of data points.  
In our previous paper we considered what would constitute a 
sufficiently significant difference in the area under the dose-
survival curve to merit a compound being considered to be less 
toxic in one vehicle than another; three levels of difference 
were considered: 30%, 40% and 60%.  Clearly the greater the 
difference needed to be considered significant, the fewer data 
would satisfy the condition.  This is shown in Figure 6 where 
increasing the difference in AUC needed to be considered 
significant reduces the number of compounds fulfilling this 
condition on going from 30% to 40% and 60%.  In this paper, 
we report the results from models built separately using all 
three differences in AUC. 
 
Figure 6: Boxplot of the variation in the number of compounds across all vehicle 
pairs considered to show a significant difference in the area under the dose-
survival curve with the size of the difference considered to be significant 
ML Model building approaches 
The idea of the ML model building was to see if it was possible 
to build models which could classify compounds as more toxic 
or less toxic when administered in one of two vehicles.  The 
classification of compounds in the training set would be made 
by the difference in the dose survival curve for the compound 
when administered in one vehicle over the other, other factors 
being the same. Frequently, it was found that where there were 
several different sets of experiments for a compound 
administered in two vehicles – for example a set of experiments 
where the host species was mouse, and a set of experiments 
where the host species was hamster – it might be the case that a 
reduction in toxicity was observed in a vehicle in one set of 
experiments, but not in the other.  Cases where compounds did 
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not show a consistent pattern across all the experiments for a 
vehicle pair fell into two types: (i) those which showed a 
combination of preference for one vehicle in some experiments 
but no preference in other experiments, which were termed 
equivocal and (ii) those which showed a preference for one 
vehicle in some experiments and for the other vehicle in other 
experiments, which were termed contradictory. The number of 
equivocal compounds was often comparable to those which 
showed a decided preference, whereas the number that were 
actually contradictory was very small. For the purposes of 
modelling, these equivocal and contradictory compounds 
together with those compounds which consistently showed no 
preference for either vehicle, were excluded; numbers of 
compounds modelled as well as the numbers excluded by being 
considered equivocal or contradictory are shown in Table 1 and 
Table 2. 
The descriptors for the model were global physico-chemical 
parameters such as Log P or molecular weight as well as other 
simple descriptors such as MACCS keys.   
In the previous paper, we reported models built using decision 
tree (DT) and random forest (RF) approaches; in this paper, we 
also report the results of models built using a Partial Least 
Squares (PLS) approach. 
PLS is commonly used when there are a large number of 
descriptors compared to the number of data points.  It is also a 
quantitative modelling approach, although refinements such as 
PLS-Discriminant Analysis (PLS-DA)29 have been developed 
for classification models.  In the models reported in this paper, 
a value of 0 or 1 was assigned to the preference of one vehicle 
over another – for instance 0 would represent less toxicity in 
CMC and 1 less toxicity in saline.  The PLS model gave a 
numerical value for the predicted vehicle with lower toxicity 
that was assigned to a category (0 or 1) based on whether it was 
greater than or less than 0.5.  The approach has been used 
successfully by others using PLS as a classification model.30 
In all three approaches, the models were built using a 10-fold 
cross-validation approach.  The folds were built ensuring that 
the class ratio in the training sets matched that of the dataset as 
a whole.  Possible descriptors were correlated with the observed 
classification of the compounds in the training set and the most 
strongly correlating were selected.  For the DT and RF models 
the number of descriptors selected was equal to one tenth of the 
number of compounds in the training set.  For the RF models, 
the random forest was rebuilt 100 times each with a different 
seed value, ensuring the RF models gave rise to different 
predictions.  For the PLS models the number of descriptors was 
varied in the range 5, 10, 20, 50; the maximum number of 
components allowed in the PLS model was one-tenth of the 
number of data points. 
In all cases, the datasets to be modelled had to consist of at least 
50 compounds. 
For each of the models, the metric that was used to measure 
performance was the balanced accuracy of the classification.  In 
practice it was found that the datasets being modelled were 
quite balanced with all biases being 2.2:1 or less. 
Statistical approach to validating the models  
When considering if the results from a model are significant, 
there are different tests that need to be passed: are the results 
from the model better than those that might be expected from 
building a model where there is no relationship between the 
feature being modelled and the descriptors used to build the 
model; is there a rationale for why the descriptors used in the 
model would be able to predict the activity modelled? 
In this paper, the models are subjected to a rigorous statistical 
analysis to demonstrate that they do indeed satisfy the criteria 
for being considered statistically significant. 
To this end, for each DT and PLS model where we wanted to 
confirm that the prediction could not have occurred by chance, 
300 models were built using a y-randomisation process31 (also 
known as target shuffling) in which the datasets from which the 
models were built had the preference for one vehicle over 
another randomised; descriptors were then selected by 
correlation with the randomly assigned preference and models 
built as previously.   
 
Figure 7: Histogram of the balanced accuracies of y-randomised PLS models for 
the classification of 123 compounds as having their toxicity reduced by either 
saline or CMC, in green.  The blue line represents a normal distribution having 
the same mean and standard deviation as the distribution of balanced accuracies 
from the y-randomised models.  The red line indicates the balanced accuracy of 
the model built with the real classification of the 123 compounds. 
For each DT and PLS model, the value of the balanced 
accuracy of the real model was compared with the distribution 
of balanced accuracies from the y-randomised models.  The 
balanced accuracy of the real model was considered to show a 
statistically significant difference to the distribution of the 
balanced accuracies of the y-randomised models if it were in or 
above the distribution’s 99th percentile, as calculated by the 
empirical cumulative distribution function.  Figure 7 shows a 
typical histogram of the distribution of balanced accuracies of 
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300 y-randomised PLS models for the classification of 123 
compounds as having decreased toxicity in either saline or 
CMC where the area under the dose-survival curve has been 
calculated by extrapolating in both the high and low dose 
regions and a difference in the AUC of 40% was needed in 
order that the toxicities in the two different vehicles was 
considered different.  Superimposed on the histogram is a 
normal distribution with the same mean and standard deviation 
as the distribution and the value of the balanced accuracy of the 
real model.  In this case the real model balanced accuracy is at 
the 99.7th percentile of the distribution. 
In the case of the RF models, 100 y-randomisations were done 
and each y-randomisation was modelled 100 times to be 
comparable with the set of real RF models.  The question of 
difference of the RF models from random thus involved 
comparing the distribution of balanced accuracies from the real 
model with each of 100 distributions from the y-randomised 
models.  When comparing two distributions, it is 
straightforward to show whether or not they may be drawn 
from the same distribution using a t-test, but we were interested 
in measuring how much of an improvement over random each 
experiment represented.  Two approaches to this were 
investigated. 
Firstly, quantifying the overlap, as shown in Figure 8, between 
the distribution of real balanced accuracies and each of the 
distributions of y-randomised balanced accuracies. An 
approximation to the overlap proportion for the two 
distributions was done by (1) partitioning the balanced accuracy 
and producing histographic density estimates over the partition 
for both of the distributions and (2) adding up the minimum 
density for each partition.  For completely separate distributions 
the overlap would be zero whilst for a situation where the real 
and random models produced identical distributions the overlap 
would be 100%. The distributions of the y-randomised models 
for 45 different combinations of vehicle pair and modelling 
conditions showed a fair amount of consistency, with median 
values between 55% and 64%; as a result, real models with a 
low performance (i.e. models which would fail the validation 
process) could still show a low overlap – so it was important to 
measure only those cases where the median of the distribution 
of balanced accuracies from the real models was greater than 
that of the y-randomised ones.  In this study, the value of the 
overlap is recorded but not used by itself as a discriminating 
value for the significance of the experiment.  The overlap 
coefficient remains popular for comparing two population 
distributions in many fields.32,33 .  
The second approach to measuring the improvement of the real 
model over the set of y-randomised models involved estimating 
the chance that a value taken at random from the distribution of 
balanced accuracies of the real models was greater than one 
taken from each of the distributions of balanced accuracies 
from the y-randomised models. As this is a Monte Carlo 
procedure, it is also trivial to calculate standard errors for the 
probability estimate. 
 For the collection of RF models to be considered as having 
outperformed the y-randomised models, the mean of the above 
probability value had to be greater than 80%.  This was an 
arbitrary cut-off, but there is little previous work to suggest an 
alternative. 
 
 
Figure 8: Histograms of balanced accuracy for real (blue) and one of the 100 y-
randomised (red) models of 107 compounds which show a difference in toxicity 
between HPC and saline with Tween-80, extrapolating the dose-survival curve in 
both the high- and low-dose regions and using a difference in the AUC of the 
dose-survival curve of 30% as showing a difference in toxicity.  The purple area 
indicates the overlap of the two distributions. 
ML Model building results 
DT and PLS models 
The results of the DT and PLS experiments are summarised in 
Table 1 for those combinations of vehicle pair, 
interpolation/extrapolation and AUC significance where the 
performance based on balanced accuracy was found to be at or 
above the 99th percentile of the distribution of balanced 
accuracies of the 300 corresponding models built from y-
randomised data as calculated by the empirical cumulative 
distribution function. 
As can be seen, both in quantity of models and in their overall 
performance the PLS modelling technique yields better results 
than the DT technique.  Four of the combinations are for 
compounds where a difference in toxicity is observed when 
using saline and CMC, though the best performing – in terms of 
both balanced accuracy and improvement over the y-
randomised models are the datasets of compounds where the 
comparison is between HPC and saline with Tween-80 
RF models 
There were 14 combinations of vehicle pair, 
interpolation/extrapolation and AUC significance, covering six 
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different vehicle pairs, where the RF models were considered as 
significantly outperforming random. 
In Figure 9 the distributions of probabilities that the real model 
outperforms a y-randomised model are shown for the 14 
combinations where the mean of the distribution was 80% or 
more.  Note that the medians of these distributions tend to be 
90% or more.  Eight of the combinations relate to the saline vs. 
CMC pair, i.e. out of the nine possible combinations of 
interpolation/extrapolation and AUC significance for this 
vehicle pair, eight are considered to allow the building of RF 
models which outperform random.  Of particular note are the 
results for the set of 92 compounds where, when the dose-
survival curve is extrapolated only at the high dose range and a 
threshold of 60% is used for the difference in the AUC of the 
dose-survival curve, 100 RF models were built and all but one 
had a probability of 100% that they outperformed a model built 
on y-randomised data (i.e. all but one had zero overlap between 
the distributions of balanced accuracies of the real and y-
randomised models). 
The results in Table 2 give more details of these sets of models 
and it can be seen that the mean of the overlap in balanced 
accuracy distribution is always <20%  
 
 
Table 1: Performance of nine models for four different vehicle pairs where the modelled dataset, N, was 50 compounds or more and the balanced accuracy was at or 
above the 99
th
 percentile of the distribution of balanced accuracies for 300 y-randomised models of the same data.  Interpolation/ Extrapolation is how the area 
under the dose-toxicity curve has been treated: Interpolation only means no extrapolation has taken place; high and high-low indicates that the data has been 
extrapolated at the high-dose or both the high- and low-dose ranges. AUC is the difference in areas under the dose-survival curve needed before it is considered 
significant. Equivocal is the number of compounds, not included in the modelling, which showed lower toxicity in one vehicle in some experiments but no difference 
in others. Contradictory is the number of compounds which showed lower toxicity for one vehicle in some experiments and for the other vehicle in other 
experiments. Percentile is the percentile of the balanced accuracy of the real model in the distribution of balanced accuracies for the y-randomised models. HPC is 
hydroxypropylcellulose (Klucel) 
Vehicle pair 
Interpolation/ 
extrapolation 
A
U
C
/%
 
N
 
(less to
x
ic in
 first 
v
eh
icle: seco
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d
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icle) 
E
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u
iv
o
cal 
C
o
n
trad
icto
ry
 
M
o
d
ellin
g
 m
eth
o
d
 
B
alan
ced
 accu
racy
 
P
ercen
tile 
Saline vs. CMC Extrapolate high-low 40 123 (69:54) 100 14 PLS 76% 99.7 
Saline vs. CMC Extrapolate high-low 40 123 (69:54) 100 14 DT 69% 100 
Saline vs. CMC Interpolation only 60 66 (43:23) 55 2 PLS 83% 99.0 
Saline vs. CMC Extrapolate high-low 60 79 (49:30) 76 4 PLS 85% 99.7 
Saline vs. HPC Extrapolate high-low 30 116 (69:47) 42 3 PLS 80% 99.3 
Saline vs. HPC Extrapolate high 30 131 (72:59) 44 3 DT 69% 99.7 
Saline vs. Saline with Tween-80 Extrapolate high-low 30 165 (92:73) 81 9 PLS 75% 99.0 
HPC vs. Saline with Tween-80 Extrapolate high-low 30 107 (56:51) 45 7 PLS 86% 99.7 
HPC vs. Saline with Tween-80 Extrapolate high 30 116 (59:57) 45 8 PLS 86% 100 
V
eh
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latio
n
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latio
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A
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N
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o
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n
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icto
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M
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/%
 
M
ean
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ility
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m
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g
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etter th
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o
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/%
 (S
D
) 
M
ean
 o
v
erlap
 b
etw
een
 real 
an
d
 ran
d
o
m
 m
o
d
els (S
D
) 
Saline vs. Water Extrapolate high 30 50 (29:21) 54 12 73 91 (20) 9 (16) 
Saline vs. Saline with Tween-80 Extrapolate high-low 40 119 (62:57) 53 6 63 85 (23) 16 (18) 
Saline vs. MC Interpolation only 30 60 (39:21) 19 3 69 81 (24) 17 (17) 
Saline vs. HPC Interpolation only 40 68 (36:32) 32 0 70 81 (28) 13 (16) 
Saline vs. CMC Interpolation only 60 66 (43:23) 55 2 71 94 (17) 8 (14) 
Saline vs. CMC Interpolation only 40 108 (68:40) 87 9 63 84 (27) 15 (16) 
Saline vs. CMC Interpolation only 30 144 (95:49) 106 18 62 90 (21) 12 (16) 
Saline vs. CMC Extrapolate high 60 92 (58:34) 70 6 79 100 (1) 0 (0) 
Saline vs. CMC Extrapolate high 40 130 (78:52) 99 15 63 91 (21) 13 (20) 
Saline vs. CMC Extrapolate high 30 164 (103:61) 112 26 61 89 (22) 13 (17) 
Saline vs. CMC Extrapolate high-low 60 79 (49:30) 76 4 73 98 (11) 3 (7) 
Saline vs. CMC Extrapolate high-low 40 123 (69:54) 100 14 66 94 (14) 10 (15) 
Page 7 of 12 Toxicology Research
To
xi
co
lo
gy
R
es
ea
rc
h
A
cc
ep
te
d
M
an
us
cr
ip
t
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
1 
O
ct
ob
er
 2
01
6.
 D
ow
nl
oa
de
d 
on
 0
1/
11
/2
01
6 
08
:1
6:
08
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/C6TX00303F
ARTICLE Journal Name 
8 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 2012 
Table 2: Summary of performance metrics and significance measures for 100 RF models of each of 14 combinations of vehicle pairs, interpolation/extrapolation and 
AUC significance. Explanation of Interpolation/extrapolation, AUC, N, equivocal and contradictory is given in Table 1. 
 
Figure 9: Boxplots of mean probability that a RF model outperforms a y-randomised model for 14 combinations of vehicle pair, interpolation/extrapolation and AUC 
significance.  Experiments with the same vehicle pair are shown in the same colour. 
Whilst considering that the models all show a performance 
which can be considered statistically significant, the actual 
balanced accuracies of the RF models are modest – in the range 
61 – 79% - so are less than the PLS models.  As with the DT 
and PLS models, the performances of the models for the 
compounds which show a difference in toxicity between saline 
and CMC are among the best.  This suggests that not only can 
this difference in toxicity due to the dosing vehicle be modelled 
but that the descriptors used in making the models capture well 
which compounds will show that difference. 
RF model analysis 
The performance of the models and the demonstration of their 
statistical significance suggests that they merit some 
investigation to see if the descriptors that are found to be 
significant can be rationalised. 
One of the main reasons for variation in formulation – 
including variation in administration vehicle – is ensuring the 
drug compound is held in solution or in an emulsion or gel and 
so prevented from precipitating.  For instance, cellulose-derived 
vehicles are thought to form a complex with the drug where the 
vehicle encapsulates the drug compound and therefore will 
change not only the solubility but the distribution of the drug 
compound. 
There are a few studies where the effect of vehicle on toxicity is 
understood, for example nitrogen mustards have been used as 
cytotoxic drugs and are known to have their toxicity (and anti-
tumour activity) reduced in acid media34,35 due to the 
protonated nitrogen being unable to form the reactive 
aziridinium ion.36   However, as far as we know, there is little 
systematic work rationalising the effect of vehicle on toxicity 
and it is hoped that this work might help in such a study. 
To that end a set of 100 RF models of the whole dataset (rather 
than cross-validation subsets) for classifying compounds as less 
toxic in either saline or CMC using the settings of the best 
performing model (interpolation/extrapolation set to 
‘extrapolate high’ and significance threshold set to 60%) was 
analysed to see which were the most impactful descriptors in 
the models. This study was done using RF models developed in 
R (which has the same RF algorithm as the KNIME Weka 
nodes used in the modelling reported above).  The results are 
shown in Table 3: Most impactful descriptors in RF models of 
toxicity of compounds in saline or CMC.Table 3. 
 
HPC vs. Saline with Tween-80 Interpolation only 40 62 (26:36) 32 5 71 88 (23) 7 (9) 
HPC vs. Saline with Tween-80 Extrapolate high-low 30 107 (56:51) 45 7 66 88 (23) 7 (12) 
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Descriptor Saline > CMC 
rank 
CMC > saline 
rank 
Indigo Number of heteroatoms  1 1 
RDKit Number of Lipinski 
Hydrogen bond acceptors 
2 4 
Indigo Number of aliphatic atoms 3  
CDK MACCS key 160: CH3 4 5 
CDK MACCS key: 137 
HETEROCYCLE 
5  
CDK MACCS key: 109 ACH2O  2 
MACCS key: 120 
HETEROCYCLIC ATOM > 1 
 3 
Table 3: Most impactful descriptors in RF models of toxicity of compounds 
in saline or CMC.  RDKit, Indigo and CDK MACCS are the sources of 
different descriptors. 
In this case there is a high degree of similarity between the 
descriptors influencing the prediction of lower toxicity in saline 
and lower toxicity in CMC.  In addition, it can be seen that the 
descriptors reflect substructural features rather than whole 
structure properties such as solubility, log P or molecular 
weight (all of which were available to the RF models).  The 
descriptors, three of which were also found to be significant in 
our earlier study,27 also suggest a relationship with the ability to 
form hydrogen bonds through the presence of a 
heteroatom/heterocycle or an explicit count of hydrogen bond 
acceptors.   Further analysis of the descriptors is beyond the 
scope of this work. 
In terms of application of the models, whilst the statistical 
analysis presented here shows that it is indeed possible to 
model the influence of the vehicle on toxicity, without a 
scientific rationale the models can only be used as a starting 
point for suggesting formulation strategies.  There is 
insufficient data to attempt refinements such as species specific 
formulations. 
Investigation into differences shown by clusters of 
compounds 
Among the datasets which contained fewer than 50 compounds, 
there were a few results of note.  In particular, the vehicle pairs 
of distilled water & alcohol (DWA) vs. CMC all the models 
correctly classified groups of 11 or 14 compounds entirely 
correctly.  The datasets that were classified correctly were all 
classified in the same way: compounds containing an aziridine 
ring were classified as less toxic in CMC than in DWA; all the 
compounds showing the reverse toxicity profile did not contain 
an aziridine ring (and, further, did not contain any other 
obvious common feature).  Of the compounds containing an 
aziridine ring, many of them were diaziridylphosphoramides 
(DAPs) with the substructure shown in Figure 10. 
This finding suggested that a clustering approach could be 
taken to investigate differences in toxicity for related 
compounds between sets of vehicles. 
Using the DAP structure shown in Figure 10 to search the 
complete dataset for compounds with this substructure, 22 
compounds were found for which there were data where the 
compound had been administered in both DWA and CMC.  
With such a small sample, the preference for CMC vs. DWA 
was examined with no threshold for the difference in the area 
under the dose-survival curve, but some rigor was introduced 
by considering that the area comparison had to be in the same 
direction however the interpolation or extrapolation were made 
and this was true irrespective of all other variable factors in the 
data, so the 22 compounds were represented by 28 sets of 
experiments where both CMC and DWA had been used.  The 
areas under the curve were considered using all three 
interpolation/extrapolation strategies and found that a core 
group of 17 compounds always showed less toxicity in CMC, 4 
always showed less toxicity in DWA and one always showed 
no preference. 
It appears therefore, that drug compounds with the substructure 
shown in Figure 10 might generally be formulated in CMC to 
reduce toxicity over a DWA vehicle. 
Other differences for compounds with the substructure in 
Figure 10 were investigated.  For the four vehicles saline, 
CMC, MC and DWA, 83 compounds were found with data for 
at least one pair.  In analysing the distribution of compounds 
between vehicle pairs, the approach taken was that a difference 
in toxicity was considered to be shown if the number of 
compounds with lower toxicity in one vehicle was greater than 
the number with lower toxicity in the other vehicle plus the 
number showing no difference in toxicity; where this was not 
the case, it was considered that the cluster of compounds 
showed no difference between the vehicle pair.  Thus, for the 
83 compounds containing the DAP structure, where the 
distribution between each pairs is shown in Table 4, and as 
reported above, it is considered that the cluster shows less 
toxicity in CMC compared to a vehicle of DWA by 17 to 4 with 
one showing no difference.  Similarly, the cluster shows less 
toxicity in CMC than in MC by 9 to 5, again with one 
compound showing no difference. 
The data in Table 4 show a self-consistent set of relationships 
in the order of the toxicity of the four vehicles with respect to 
compounds defined by the substructure shown in Figure 10, 
which can be expressed as saline > CMC > MC > DWA where 
‘>’ means ‘shows greater survival than’; the relationships are 
represented graphically in Figure 11.  These results could be 
considered to be a small rule base for choosing a vehicle for 
DAP drug compounds. It is important to be aware that these are 
trends for the cluster of 83 DAP compounds and not for 
individual compounds.  Indeed, only one compound of the 83, 
ThioTEPA, had data for all six pairs, and ThioTEPA itself did 
not follow all the rules.  Nevertheless, ThioTEPA is commonly 
administered in distilled water or saline.37,38 
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  Preference ratio shown by cluster (Less toxic: 
more toxic: no difference) 
Less 
toxic 
vehicle 
More 
toxic 
vehicle 
DAPs 
 
Aziridines 
 
NP(=[O,S])(N)(N) 
CMC DWA 17:4:1 26:17:3 14:2:1 
Saline DWA 22:11:0 30:18:3 11:4:0 
MC DWA 8:5:0 12:12:5 - 
CMC MC 9:5:1 19:12:3 - 
Saline CMC 18:7:9 39:18:17 13:7:9 
Saline MC 7:3:1 15:8:5  
Table 4: Differences in toxicity found for clusters of compounds containing 
the DAP structure shown in Figure 10, aziridines and phosphoramides.  
Figures in italics indicate that there is not considered to be a difference in 
toxicity shown by the two vehicles in the pair. 
Other clusters of compounds were investigated.  A related 
cluster of 149 compounds containing an aziridine ring showed 
similar relationships between the four vehicles, although as the 
number of compounds found to be less toxic when administered 
with MC rather than DWA was not greater than the number of 
compounds showing the reverse relationship and the number 
showing equality, the relationships between the four vehicles 
could be expressed as saline > CMC > MC = DWA, where, 
again,  ‘>’ means ‘shows greater survival than’ and ‘=’ means 
‘shows the same survival as’.  In contrast, for a cluster of 38 
phosphoramides defined with the SMARTS string 
NP(=[O,S])(N)(N) there were only enough data for the 
relationships between three of the vehicles (see Table 4) and the 
relationships were saline = CMC > DWA. 
P
O,S
N
N
R1
 
Figure 10: Diaziridylphosphoramide (DAP) derivatives which were seen to show a 
different toxicity profile in CMC than in distilled water & alcohol. 
 
 
Figure 11: Relationships between different toxicity profiles for compounds of the 
DAP shown in Figure 10.  Arrows go from the vehicle with the lower toxicity to 
the vehicle with the higher toxicity (i.e. ‘safer’ to ‘less safe’).  Labels on the 
arrows indicate the number of DAPs which are found for the vehicle pair to be 
less toxic: more toxic: no difference.  A similar arrangement of nodes can be 
drawn for the aziridines and a subset of the nodes can be drawn for the 
phosphoramides. 
The preference ratios for the three clusters represent fully 
ordered sets where all the relationships have sufficient – and 
non-contradictory – data.  For a cluster of 63 platinum 
containing compounds, data were found for five of the six 
different vehicle pairs from saline & Tween-80, HPC, water 
and saline.  For these compounds there was insufficient data for 
the saline & Tween-80 vs. water combination.  However, the 
five relationships which were found suggested the toxicity for 
platinum containing compounds varied saline > HPC = water > 
saline & Tween-80 and gave a full ordering of the four vehicles 
as can be seen in Figure 12. 
With a set of 54 compounds containing a sulphonic acid group, 
including compounds with an alkyl sulphonate counterion, with 
the vehicles sonified saline, saline, saline & Tween-80 and 
HPC, data were found again for five of the six possible 
relationships and were again able to form a fully order set.  In 
this case there was no preference shown between saline, saline 
& Tween-80, and HPC so the relationships can be summarised 
as sonified saline > saline = saline & Tween-80 = HPC as 
shown in Figure 13. 
The five clusters of compounds referred to in this section, 
together with the vehicle shown to be less toxic from each pair 
for which there are data are supplied as SD files in the 
supplementary data.  
Several other experiments on clusters defined by groups such as 
arsenic compounds, nitrogen mustards, quinones, aryl 
carboxylic acids or simply multi-component compounds were 
also performed but resulted only in equivalency of several 
different vehicles, or single vehicle pair relationships which 
could not be put in a wider context.  There were also cases 
where inconsistent relationships were recorded for example 
among a cluster of nitrogen mustards the inconsistent 
relationships HPC > saline & Tween-80, CMC=HPC, 
CMC=saline & Tween-80 were found.  Nevertheless, the self-
consistent sets of relationships found in the discussion above 
suggests the approach has some merit. 
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Figure 12: Relationships between different toxicity profiles for a cluster of 63 
platinum-containing compounds.  Arrows go from the vehicle with the lower 
toxicity to the vehicle with the higher toxicity (i.e. ‘safer’ to ‘less safe’).  Labels on 
the arrows indicate the number of compounds which are found for the vehicle 
pair to be less toxic: more toxic: no difference.  Where two or more vehicles are 
not considered to show a difference in toxicity, a double headed arrow is used 
and the label indicates less toxic on the left: less toxic on the right: no difference.  
 
Figure 13: Relationships between different toxicity profiles for a cluster of 54 
sulphonic acids.  Arrows go from the vehicle with the lower toxicity to the vehicle 
with the higher toxicity (i.e. ‘safer’ to ‘less safe’).  Labels on the arrows indicate 
the number of compounds which are found for the vehicle pair to be less toxic: 
more toxic: no difference. Where two or more vehicles are not considered to 
show a difference in toxicity, a double headed arrow is used and the label 
indicates less toxic on the left: less toxic on the right: no difference. 
Experimental work 
The dataset was provided by the National Institute of Health’s 
Developmental Therapeutics Program28 and was curated as 
described previously27 to give a dataset of 2297845 records 
relating to 221656 drug compounds.  52 different vehicles were 
considered giving 1326 unique vehicle pairs. 
All modelling and clustering were done with KNIME version 
2.12.2.  In this environment, descriptors were obtained from the 
RDKit and Indigo descriptor nodes and CDK MACCS 
fingerprints node; PLS models were built with the Weka 3.6 
nodes, RF models were built with Weka 3.7 nodes and DT 
models were built with the KNIME base nodes. Statistical 
analyses were performed using R nodes running version 3.0.3 
of R sub versioned 201508240951.  Chemical substructure 
searches were performed using the RD Kit Substructure filter. 
KNIME workflows representative of the experiments reported 
in this paper are available as supplementary data. 
Conclusions 
We have shown that models can be made for classifying which 
of a pair of vehicles for a drug compound can result in lower 
toxicity. 
We have demonstrated that the approach works for several 
pairs of vehicles, and that a statistically rigorous evaluation of 
the results demonstrates that they have not come about by mere 
chance.  We find that models built using PLS techniques give 
better predictive performance than those built with RF or DT 
methods. 
We have also presented a method of ordering the relative 
toxicities shown by vehicle pairs for a series of clusters which 
generally lead to self-consistent ordered sets of vehicles.   
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